Actively Recruiting
CirrhosisRx CDS System
Led by University of California, San Francisco · Updated on 2026-04-01
2106
Participants Needed
1
Research Sites
102 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the study is to compare the effect of CirrhosisRx, a novel clinical decision support (CDS) system for inpatient cirrhosis care, versus "usual care" on adherence to national quality measures and clinical outcomes for hospitalized patients with cirrhosis.
CONDITIONS
Official Title
CirrhosisRx CDS System
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Diagnosis of cirrhosis based on chronic liver disease and cirrhosis or its complications by ICD-10 codes or clinical documentation
- Currently admitted as inpatients at the study institution
You will not qualify if you...
- Children younger than 18 years
- Patients who do not meet the cirrhosis diagnosis criteria
- Patients who are ambulatory (not hospitalized)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California San Francisco Medical Center
San Francisco, California, United States, 94143
Actively Recruiting
Research Team
J
Jin Ge, MD, MBA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here